维普中文期刊产品整合服务
7篇 您的检索式:作者名="Luvero"
    题名 作者 年代 出处 被引量
1Treatment options in recurrent ovarian cancer:latest evidence and clinical po- tential显示文摘Luvero D Milani A Ledermann JA 2014Ther Adv Med 0neol2014,6,5:1
2Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma?显示文摘Roberto Angioli Francesco Plotti Stella Capriglione Alessia Aloisi Roberto Montera Daniela Luvero Andrea Miranda Ester Valentina Cafà Patrizio Damiani Pierluigi Benedetti-Panici 2012Gynecologic Oncology2012,,:1
3The role of novel biomarker HE4 in endometrial cancer: a case control prospective study显示文摘Roberto Angioli Francesco Plotti Stella Capriglione Roberto Montera Patrizio Damiani Roberto Ricciardi Alessia Aloisi Daniela Luvero Ester Valentina Cafà Nella Dugo Michela Angelucci Pierluigi Benedetti-Panici 2013Tumor Biology2013,,:1
4Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer : a pilot study 显示文摘Angioli R Plotti F Luvero D 2014Tumour Bio12014,35,3:1
5Feasibility and safety of car- boplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer:A pilot study显示文摘Angioli R Plotti F Luvero D 2013Tumour Biol2013,11,3:1
6Treatment options in recurrent ovarian cancer:latest evidence and clinical potential显示文摘Luvero D Milani A Ledermann JA 2014Ther Adv Med Oncol2014,6,5:1
7Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study显示文摘Angioli R Plotti F Luvero D 2014Tumour Biol2014,35,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费